Search Results For ''

  • Youfoodz to cut losses by voting in favour of opportune takeover by HelloFresh

    An extraordinary period for shareholders in meal delivery company Youfoodz (ASX: YFZ) is set to come to a close, albeit many are likely to be disgruntled with the Company recommending a takeover bid from rival HelloFresh at a whopping 57% discount on their IPO price just 8 months earlier. The takeover has come by way

    Read More
    Public
  • Wesfarmers to enter healthcare with $687m takeover of Priceline

    Retail conglomerate Wesfarmers (ASX: WES) is set to create a new health and wellbeing division to service one of Australia’s fastest growing industries via the acquisition of Australian Pharmaceutical Industries (ASX: API), the operators of Priceline Pharmacies. A non-binding offer has been presented to the Board of API to acquire 100% of the shares on

    Read More
    Public
  • PharmAust partners with the Walter and Eliza Hall Institute to expand COVID-19 research

    Forging ahead with their lead drug candidate, PharmAust (ASX: PAA) is expanding on their COVID-19 program. Their new angle is to investigate the effects of monepantel (MPL) on human T-lymphotropic virus-1 (HTLV-1) infections in partnership with leading biomedical research organisation, the Walter and Eliza Hall Institute (WEHI), based in Melbourne. The HTLV-1 virus is a

    Read More
    Public
  • Regulators approve LiveVerdure’s turmeric capsules to alleviate joint pain

    Joint pain continues to emerge as one of the most debilitating conditions among Australia’s aging population but that can now be addressed with superfoods company LiveVerdure’s (ASX: LV1) latest product TheraJoint+, turmeric capsules that have been approved by Australia’s Therapeutic Goods Association (TGA). TheraJoint+ is part of LiveVerdure’s 13 Seeds brand and is the brand’s

    Read More
    Public
  • A slice of the After-pie: NZ’s leading BNPL is making strides in responsible credit

    New Zealand’s leading BNPL provider, Laybuy (ASX: LBY) has reported an impressive year across the board, proving that there is space yet to grow in the seemingly saturated sector.  Since its inception in 2017, Laybuy has gone from strength to strength with a seemingly well timed entry into the BNPL market.  Laybuy is now recognised

    Read More
    Public
  • LBT Innovations to present clinical data at leading industry conference

    Adelaide-based medtech company LBT Innovations (ASX: LBT) is moving nicely along the path to commercialise their flagship product, presenting clinical data at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), which will be held online over the weekend. The ECCMID represents the largest global conference for clinical microbiology and is a unique opportunity

    Read More
    Public